Global Information
회사소개 | 문의

사마귀 : 파이프라인 리뷰

Warts - Pipeline Review, H1 2019

리서치사 Global Markets Direct
발행일 2019년 02월 상품 코드 200501
페이지 정보 영문 101 Pages
가격
US $ 2,000 ₩ 2,274,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,549,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,000 ₩ 6,824,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


사마귀 : 파이프라인 리뷰 Warts - Pipeline Review, H1 2019
발행일 : 2019년 02월 페이지 정보 : 영문 101 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

사마귀는 인유두종 바이러스(HPV)에 의한 작고 통증이 없는 국소적인 피부 종양을 가리킵니다. 사마귀에는 다양한 종류가 있으며, 손등에 나타나는 보통 사마귀 및 안면·이마의 편평 사마귀, 성기에 발생하는 음부 사마귀(콘딜로마), 발바닥에 발생하는 발바닥 사마귀, 손톱·발톱 아래 및 주위에 발생하는 손발톱 사마귀 등을 들 수 있습니다. 주요 증상에는 구진 주위의 피부가 극단적으로 검거나 희게되는 것, 이마·볼·팔·다리에 발생하는 다수의 작고 매끄럽고 편평한 구진, 손톱·발톱 아래 및 주위에 생기는 요철 모양의 종양, 발바닥에 있는 타원형의 구진 등이 있습니다. 형상은 모두 편평하거나 약간 융기되어 있으며, 압박감을 수반하고 작고 딱딱한 구진 및 덩어리로 되어 있습니다. 지속적 사마귀의 제거시 포도필린 및 살리실산 등의 의약품이 처방되며, 외과수술 및 냉각(냉동치료), 연소(전기 소작법) 등의 방법도 취할 수 있습니다.

세계 각국의 사마귀 치료용 파이프라인 제품 개발 상황에 대해 분석했으며, 파이프라인 제품의 최신 동향, 임상시험 각 단계별 제품 리스트, 주요 기업 개요, 주요 약제 개요(제품 개요, 기능 메커니즘, 연구개발(R&D) 진전 상황), 최신 업계 동향 등을 조사한 결과를 정리하여 전해드립니다.

서론

  • 분석 범위

사마귀 개요

치료제 개발

  • 사마귀용 파이프라인 제품 : 개요
  • 사마귀용 파이프라인 제품 : 비교 분석

각 기업에서 개발중인 사마귀 치료제

파이프라인 제품 개요

  • 임상시험 단계 제품
  • 초기 단계 제품

사마귀 치료제 : 개발중인 제품 리스트(기업별)

사마귀 치료제 개발에 종사하고 있는 기업

  • Helix BioPharma Corp.
  • CEL-SCI Corporation
  • NanoViricides, Inc.
  • 3M Drug Delivery Systems
  • G&E Herbal Biotechnology Co., Ltd.
  • Anaconda Pharma
  • Foamix Ltd.
  • BioMAS Ltd.
  • ViroStatics, srl
  • Cutanea Life Sciences
  • Burke Pharmaceuticals, LLC
  • Agilvax, Inc.
  • Nielsen Biosciences, Inc.

사마귀 : 치료제 평가

  • 단일요법 제품의 경우
  • 병용 치료제의 경우
  • 표적별
  • 기능 메커니즘별
  • 투여 방법별
  • 분자 종류별

약제 개요

  • 인터페론·알파-2b (재조합)
  • AS-101
  • SRT-100
  • AP-611074
  • Candida Albicans Antigen
  • (digoxin + furosemide)
  • Leukocyte Interleukin
  • A-101
  • BURKE-201
  • AX-03
  • HerpeCide-I
  • imiquimod
  • 854-A
  • PP-210
  • HPV 관련 암 및 사마귀를 위한 CDK9 저해용 소분자

사마귀 치료제 : 최신 약제 개요

사마귀 치료제 : 휴지 상태의 프로젝트

사마귀 치료제 : 개발이 중지된 제품

사마귀 관련 제품 개발 마일스톤

  • 주목할 만한 최신 동향·프레스 릴리스(총 8건)

부록

도표

KSA 14.10.15

List of Tables

  • Number of Products under Development for Warts, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products under Development by Companies, H1 2019 (Contd..1), H1 2019
  • Number of Products under Development by Universities/Institutes, H1 2019
  • Products under Development by Companies, H1 2019
  • Products under Development by Companies, H1 2019 (Contd..1), H1 2019
  • Products under Development by Universities/Institutes, H1 2019
  • Number of Products by Stage and Target, H1 2019
  • Number of Products by Stage and Mechanism of Action, H1 2019
  • Number of Products by Stage and Route of Administration, H1 2019
  • Number of Products by Stage and Molecule Type, H1 2019
  • Warts - Pipeline by Aclaris Therapeutics Inc, H1 2019
  • Warts - Pipeline by Cutanea Life Sciences Inc, H1 2019
  • Warts - Pipeline by Cytovation AS, H1 2019
  • Warts - Pipeline by G&E Corp, H1 2019
  • Warts - Pipeline by Genetic Immunity Inc, H1 2019
  • Warts - Pipeline by Laboratories Ojer Pharma SL, H1 2019
  • Warts - Pipeline by LEO Pharma A/S, H1 2019
  • Warts - Pipeline by Maruho Co Ltd, H1 2019
  • Warts - Pipeline by Nielsen Biosciences Inc, H1 2019
  • Warts - Pipeline by Novan Inc, H1 2019
  • Warts - Pipeline by Novartis AG, H1 2019
  • Warts - Pipeline by Pfizer Inc, H1 2019
  • Warts - Pipeline by Phio Pharmaceuticals Corp, H1 2019
  • Warts - Pipeline by Promius Pharma LLC, H1 2019
  • Warts - Pipeline by Tamir Biotechnology Inc, H1 2019
  • Warts - Pipeline by Verrica Pharmaceuticals Inc, H1 2019
  • Warts - Dormant Projects, H1 2019
  • Warts - Dormant Projects, H1 2019 (Contd..1), H1 2019
  • Warts - Discontinued Products, H1 2019

List of Figures

  • Number of Products under Development for Warts, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products under Development by Universities/Institutes, H1 2019
  • Number of Products by Top 10 Targets, H1 2019
  • Number of Products by Stage and Top 10 Targets, H1 2019
  • Number of Products by Top 10 Mechanism of Actions, H1 2019
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
  • Number of Products by Routes of Administration, H1 2019
  • Number of Products by Stage and Routes of Administration, H1 2019
  • Number of Products by Molecule Types, H1 2019
  • Number of Products by Stage and Molecule Types, H1 2019

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Warts - Pipeline Review, H1 2019, provides an overview of the Warts (Infectious Disease) pipeline landscape.

Warts are skin growth that is caused by virus called human papillomavirus (HPV). HPV infects the top layer of skin, usually entering the body in an area of broken skin. The virus causes the top layer of skin to grow rapidly, forming a wart. Symptoms include pain and rough skin. Predisposing factors include age and people with weakened immune systems, such as those with HIV/AIDS or people who had organ transplants.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Warts - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Warts (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Warts (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Warts and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 3, 14, 3, 5 and 2 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 2 and 1 molecules, respectively.

Warts (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Warts (Infectious Disease).
  • The pipeline guide reviews pipeline therapeutics for Warts (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Warts (Infectious Disease) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Warts (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Warts (Infectious Disease)

Reasons to buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Warts (Infectious Disease).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Warts (Infectious Disease) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Introduction
  • Warts - Overview
  • Warts - Therapeutics Development
  • Warts - Therapeutics Assessment
  • Warts - Companies Involved in Therapeutics Development
  • Warts - Drug Profiles
  • Warts - Dormant Projects
  • Warts - Discontinued Products
  • Warts - Product Development Milestones
  • Appendix
Back to Top
전화 문의
이용안내
 
BCC Research